Sign In
Buy PFE
$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
2 No-Brainer Dividend Stocks to Buy With $100 in November
09:15am, Saturday, 08'th Nov 2025
Coca-Cola owes its remarkable dividend streak to its brand name, pricing power, and new products. Pfizer is struggling right now, but its future looks bright considering recent moves and a cheap valua
Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer
06:38am, Saturday, 08'th Nov 2025
AbbVie's and Pfizer's Q3 earnings and dividend updates prompt a rating upgrade to Hold for ABBV and reiteration of Sell for PFE. PFE's higher yield (almost 7%) and single-digit P/E (FY1 P/E is ~8x onl
Pfizer prevails over rival Novo Nordisk after an unusual bidding war for the weight-loss startup.
Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer
09:32pm, Friday, 07'th Nov 2025
Revised transaction values Metsera at up to $86.25 per share Metsera's Board of Directors unanimously recommends that Metsera stockholders approve the adoption of the amended Pfizer merger agreement
Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports
07:59pm, Friday, 07'th Nov 2025
Pfizer has submitted a sweetened bid for obesity drug developer Metsera , as its fight against rival Novo Nordisk escalates, Bloomberg News reported on Friday.
National Advertising Division Will Refer BridgeBio Pharma to Government Agencies for Failure to Participate in Inquiry
01:00pm, Friday, 07'th Nov 2025
Following a challenge submitted by Pfizer, Inc., BBB National Programs' National Advertising Division will refer BridgeBio Pharma Inc. to the relevant government agencies for review and possible enfor
Pfizer Discusses Drug Pricing Deal, Metsera Buyout Dispute on Q3 Call
12:31pm, Friday, 07'th Nov 2025
Pfizer faces a fierce bidding war with Novo Nordisk over Metsera while securing a landmark U.S. drug pricing deal.
Pfizer: The Storm Has Passed -- Tailwinds Ahead
02:00pm, Thursday, 06'th Nov 2025
Pfizer Inc. remains a Strong Buy with a $33 price target, implying 33% upside over 12-18 months, driven by undervaluation and sector tailwinds. Despite Fiscal Q3 2025 revenue and EPS declines, PFE's f
What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war?
12:01pm, Thursday, 06'th Nov 2025
Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment their pipeline in the booming weight-loss drug market.
Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal
11:40am, Thursday, 06'th Nov 2025
The Delaware Chancery Court denied Pfizer Inc.'s (NYSE:PFE) request for a temporary restraining order to prevent Metsera, Inc. (NASDAQ:MTSR) from terminating the existing merger agreement in favor o
No Brainer Dividend Stocks To Buy Now
11:36am, Thursday, 06'th Nov 2025
You cannot know the power of an investment unless you see the returns. Many think of dividend stocks as a way of generating cash income from their portfolio, but if you handle the income well, you can
'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera
10:11am, Thursday, 06'th Nov 2025
Metsera stock surged Thursday on reports Pfizer has matched Novo Nordisk's $10 billion bid to buy the obesity-focused biotech.
Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle
08:49am, Thursday, 06'th Nov 2025
A bidding war over U.S. biotech Metsera was coming to a head on Thursday, with Danish drugmaker Novo Nordisk locked in a $10 billion battle with U.S. rival Pfizer to win Metsera's obesity drug assets.
Pfizer's Slow Burn Comeback
07:20am, Thursday, 06'th Nov 2025
Pfizer offers a 7% dividend yield, providing steady income despite stagnant share performance in recent months. COVID-19 product sales have sharply declined, with Paxlovid down 55% and vaccine revenue
Wall Street Breakfast Podcast: Government Shutdown Hits New Altitude
06:29am, Thursday, 06'th Nov 2025
FAA will reduce air traffic by 10% across 40 major markets due to staffing shortages from the government shutdown, impacting 3,500-4,000 flights daily. Pfizer (PFE) has matched Novo Nordisk's bid for
